The incidence of melanoma is increasing worldwide and despite early detection and
intervention, the number of patients dying from metastatic disease continues to rise. The …

The incidence of melanoma is increasing worldwide and despite early detection and
intervention, the number of patients dying from metastatic disease continues to rise. The …

The incidence and mortality of melanoma are on the rise. Historically, patients diagnosed
with metastatic melanoma were faced with a grim prognosis, with survival rates of 15% at 5 …

Simple Summary Progress in the treatment of malignant melanoma, particularly with the use
of immunotherapy, has markedly improved outcomes. Despite these successes, many …

Metastatic melanoma is notorious for its immune evasion and resistance to conventional
chemotherapy. The recent success of ipilimumab, a human monoclonal antibody against …

Cutaneous melanoma is the most aggressive and deadly form of skin cancer due to its high
capacity to metastasize. Over the last decades, the management of this malignancy has …

Simple Summary Immunotherapy has demonstrated the ability to reduce the risk of
recurrence for melanoma following surgical resection and improve survival in patients with …

Immunotherapy has dramatically improved the prognosis for patients with melanoma and
has become the cornerstone of treatment for those with advanced disease. The role of …

Recent years have seen major improvements in survival of patients with advanced
melanoma with the advent of various novel systemic immunotherapies and targeted …

As calculated by the meta-analysis of Korn et al., the prognosis of metastatic melanoma in
the pretarget and immunological therapy era was poor, with a median survival of 6.2 and a 1 …